IBB News and Press, iShares Biotechnology ETF From 11/15/23

2023-11-15 08:16:54 ET More on Markets Oppenheimer favors tech amid upbeat prediction for S&P 500 Cathie Wood's ARK Invest launches crypto ETFs in partnership with 21Shares Nasdaq exits correction territory, small caps rebound in Russell revenge For furth...

2023-11-14 05:40:00 ET Summary Healthcare stocks have underperformed the global market this year. Investors in healthcare stocks have been disappointed in 2023. Active investors can find attractively valued companies that benefit from durable business growth trends across the ...

2023-11-13 10:28:09 ET Summary BlackRock Health Sciences Term Trust is a closed-end fund focused on healthcare and biotech stocks with $1.69 billion under management. The fund employs a call-writing overlay and invests in venture-stage companies to try and generate outperformance....

2023-11-13 04:17:21 ET Summary US sectoral flows for October 2023 show a deficit in the domestic private sector, negatively impacting asset markets. The federal government injected $76 billion into the private sector, but bank credit creation decreased by $15 billion. Fiscal f...

2023-11-08 22:09:03 ET Summary Whatever the combination of reasons for the rally in the past two weeks, it has been most welcome. Big-cap tech and large-cap growth stocks continue to outperform, and we expect them to lead in the future. AI and cost-saving initiatives could dri...

2023-11-07 10:11:36 ET More on Markets Support holds for 'most important stock in the world' - Evercore ISI Vanguard reportedly winding down operations in China Wells Fargo sees little guidance follow-through from Q3 results For further details see: Twent...

2023-11-03 15:23:43 ET More on XBI and IBB Biopharma Bounce-Back: From Policy Pains To Profitable Plains IBB: The Illness Of Idiosyncratic Risk Jefferies is bullish on XBI at around $70 for year-end and first quarter 2024 returns Citi turns cautious on pharma...

2023-11-03 03:30:00 ET Summary Following a strong first half of 2023, third quarter returns were more challenged across almost all asset classes. One outlier was high-yield debt, which often serves as a way to de-risk equity exposures when stocks are under pressure. Most year-...

2023-10-23 12:05:00 ET Summary U.S. corporate earnings have stagnated with the economy. We stay selective in stocks and harness mega forces like artificial intelligence as key profit centers. The 10-year U.S. Treasury yield hit 16-year highs near 5.0% last week, while U.S. stocks ...

2023-10-20 15:19:09 ET You have to neutralize positions when stocks are going bad, said Joe Terranova, chief market strategist for Virtus Investment Partners. He has sold his Invesco QQQ Trust ( NASDAQ: QQQ ) position after the profit and loss was “going the wrong way on ...